Get the Stockscreener App
16.26
2.65%
0.42
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Axogen Inc stock is traded at $16.26, with a volume of 1.00M.
It is up +2.65% in the last 24 hours and up +29.67% over the past month.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.
See More
Previous Close:
$15.84
Open:
$15.96
24h Volume:
1.00M
Relative Volume:
0.93
Market Cap:
$748.16M
Revenue:
$159.01M
Net Income/Loss:
$-21.72M
P/E Ratio:
-31.27
EPS:
-0.52
Net Cash Flow:
$-20.63M
1W Performance:
+8.91%
1M Performance:
+29.67%
6M Performance:
-9.67%
1Y Performance:
+31.66%
1-Day Range:
$15.79
$16.45
1-Week Range:
$14.83
$16.45
52-Week Range:
$9.215
$21.00
Axogen Inc Stock (AXGN) Company Profile
Name
Axogen Inc
Sector
Industry
Phone
(386) 462-6817
Address
13631 PROGRESS BLVD., ALACHUA, FL
Compare AXGN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AXGN
Axogen Inc
|
16.26 | 712.73M | 159.01M | -21.72M | -20.63M | -0.52 |
|
ABT
Abbott Laboratories
|
132.59 | 226.73B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
106.17 | 152.69B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
394.22 | 145.89B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.71 | 118.91B | 33.54B | 4.69B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
81.83 | 45.97B | 5.69B | 1.41B | 577.90M | 6.95 |
Axogen Inc Stock (AXGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-17-25 | Initiated | Lake Street | Buy |
| Jul-01-24 | Initiated | Raymond James | Outperform |
| Nov-11-22 | Resumed | Jefferies | Buy |
| May-09-22 | Upgrade | Canaccord Genuity | Hold → Buy |
| Mar-11-22 | Resumed | Cantor Fitzgerald | Overweight |
| Oct-23-20 | Initiated | Guggenheim | Buy |
| Jun-16-20 | Resumed | Cantor Fitzgerald | Overweight |
| May-07-20 | Downgrade | Canaccord Genuity | Buy → Hold |
| Apr-02-20 | Downgrade | BTIG Research | Buy → Neutral |
| Aug-07-19 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jul-12-19 | Initiated | Canaccord Genuity | Buy |
| Mar-02-18 | Reiterated | Lake Street | Buy |
| Jan-05-18 | Resumed | Cantor Fitzgerald | Overweight |
| Nov-30-17 | Initiated | Jefferies | Buy |
| Nov-21-17 | Reiterated | Lake Street | Buy |
| Jul-31-17 | Initiated | Leerink Partners | Outperform |
| Jun-30-17 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-06-17 | Initiated | ROTH Capital | Buy |
| Nov-22-16 | Upgrade | Lake Street | Hold → Buy |
| Nov-07-16 | Reiterated | Wedbush | Outperform |
| Nov-03-16 | Downgrade | Lake Street | Buy → Hold |
| Aug-04-16 | Reiterated | Wedbush | Outperform |
| May-14-14 | Initiated | Dawson James | Buy |
| Oct-31-13 | Reiterated | Ladenburg Thalmann | Buy |
View All
Axogen Inc Stock (AXGN) Latest News
Axogen (AXGN) Slid on a Weaker Than Expected Gross Margin - Yahoo Finance
AxoGen price target lowered to $20 from $21 at Raymond James - MSN
How Axogen Inc. stock performs during market volatility - sundaytimes.kr
Can Axogen Inc. grow without external funding2025 Market Overview & Expert-Curated Trade Recommendations - classian.co.kr
Does Axogen Inc. fit your quant trading modelEntry Point & Advanced Technical Signal Analysis - Newser
Tools to assess Axogen Inc.’s risk profileMarket Weekly Review & Expert Curated Trade Ideas - Newser
Short interest data insights for Axogen Inc.Watch List & Fast Entry Momentum Alerts - Newser
Raymond James Slashes PT on Axogen (AXGN) to $20 From $21 - MSN
Full technical analysis of Axogen Inc. stockWeekly Trade Review & High Win Rate Trade Alerts - Newser
How to read the order book for Axogen Inc.2025 Price Action Summary & Intraday High Probability Setup Alerts - Newser
Wall Street Analysts Predict a 76.37% Upside in AxoGen (AXGN): Here's What You Should Know - MSN
Will Axogen Inc. outperform its industry peersTrade Risk Assessment & Weekly Breakout Stock Alerts - newsyoung.net
AxoGen’s SWOT analysis: nerve repair innovator’s stock poised for growth By Investing.com - Investing.com Nigeria
AxoGen’s SWOT analysis: nerve repair innovator’s stock poised for growth - Investing.com India
Axogen Inc. Recovery Likely Here’s What Data ShowsJuly 2025 Weekly Recap & Community Shared Stock Ideas - metal.it
Axogen Inc. stock retracement – recovery analysis2025 Growth vs Value & Free Risk Controlled Daily Trade Plans - Newser
Axogen's Strategic Position in the Evolving Peripheral Nerve Repair Market: A Deep Dive into Clinical Success, Regulatory Momentum, and Growth Potential - AInvest
Axogen: Broad Range Of Outcomes Still Present, Opting To Remain Sidelined - Seeking Alpha
Cantor Fitzgerald reiterates Overweight rating on AxoGen stock after strong Q2 By Investing.com - Investing.com South Africa
Cantor Fitzgerald reiterates Overweight rating on AxoGen stock after strong Q2 - Investing.com
Zurcher Kantonalbank Zurich Cantonalbank Invests $146,000 in AxoGen, Inc. (NASDAQ:AXGN) - Defense World
IBD Rating Upgrades: Axogen Shows Improved Price Strength - Investor's Business Daily
Leading vs lagging indicators on Axogen Inc. performanceTrade Alert System with Volume Analysis - Newser
How high can Axogen Inc. stock goSector Rotation Outlook With Historical Summary - Newser
Price momentum metrics for Axogen Inc. explainedFree Real Time Stock Movement Analysis - Newser
Axogen Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
FY2025 EPS Estimates for AxoGen Raised by Cantor Fitzgerald - Defense World
Is now a turning point for Axogen Inc.Market Forecast Summary Over Multi-Year Period - Newser
AxoGen (NASDAQ:AXGN) Upgraded to Buy at Wall Street Zen - Defense World
Can volume confirm reversal in Axogen Inc.Low Drawdown Picks with Weekly Updates - Newser
Ichimoku Cloud Indicates Uncertainty Around Axogen Inc.Expert Verified Stock Trade Ideas Backed by Data - beatles.ru
Axogen Inc Reports Strong Q2 2025 Earnings with 18.3% Revenue Growth and BLA Approval Expected in September - AInvest
AxoGen’s Earnings Call: Strong Growth Amid Challenges - The Globe and Mail
AxoGen (AXGN) Beats Q2 Earnings and Revenue Estimates - NewsBreak: Local News & Alerts
Axogen 2025 Q2 Earnings Returns to Profitability with 130.1% Net Income Jump - AInvest
Axogen raises 2025 revenue growth target to at least 17% as BLA approval nears - MSN
AxoGen, Inc. (NASDAQ:AXGN) Q2 2025 Earnings Call Transcript - Insider Monkey
Axogen Reports Strong Q2 2025 Financial Results - The Globe and Mail
How to build a custom watchlist for Axogen Inc.Free Stock Selection With High Accuracy - Newser
AxoGen: Q2 Earnings Snapshot - Stamford Advocate
Axogen Inc (AXGN) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Advancements - Investing.com Canada
Risk adjusted return profile for Axogen Inc. analyzedRisk-Managed Swing Setup and Signal Analysis - Newser
Axogen, Inc. Reports Strong Revenue Growth in Q2 2025 - TipRanks
Axogen (AXGN) Q2 Revenue Jumps 18% - AOL.com
AxoGen stock price target lowered to $20 by Raymond James on BLA timing - Investing.com Nigeria
Axogen (AXGN.O) Sees Sharp Intraday Move—What's Driving the Volatility? - AInvest
AxoGen reports Q2 adjusted EPS 12c, consensus 6c - TipRanks
AxoGen Q2 2025 Earnings Call Transcript - MarketBeat
Jefferies raises AxoGen stock price target to $25 on strong sales growth - Investing.com India
Jefferies raises AxoGen stock price target to $25 on strong sales growth By Investing.com - Investing.com South Africa
Axogen's Q2 2025 Earnings Call: Unpacking Contradictions in Margins, BLA Milestones, and Growth Strategies - AInvest
Axogen Inc Stock (AXGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Axogen Inc Stock (AXGN) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Levine Alan M | Director |
Jun 09 '25 |
Sale |
10.61 |
4,073 |
43,215 |
36,743 |
| Wendell Amy McBride | Director |
Jun 09 '25 |
Sale |
10.61 |
4,073 |
43,215 |
93,826 |
| Burke William P. Mr. | Director |
Jun 09 '25 |
Sale |
10.61 |
4,073 |
43,215 |
24,484 |
| NEELS GUIDO J | Director |
Jun 09 '25 |
Sale |
10.61 |
4,073 |
43,215 |
86,743 |
| JOHNSON JOHN | Director |
Jun 09 '25 |
Sale |
10.61 |
4,073 |
43,215 |
24,943 |
| TYNDALL JOSEPH A. | Director |
Jun 10 '25 |
Option Exercise |
6.56 |
11,586 |
75,952 |
26,931 |
| TYNDALL JOSEPH A. | Director |
Jun 10 '25 |
Sale |
10.72 |
26,931 |
288,700 |
0 |
0.89%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):